Raadi | Blue Cross MN

Soo bandhiga 2351 - 2360 ee natiijooyinka 3167

Bixiye

P59-20 Medical Oncology Drug Prior Authorization Updates for Fully Insured Commercial and Medicare Advantage Subscribers – eviCore Healthcare Specialty Utilization Management (UM) Program

Wax badan akhri

Taariikhda barnaamijka Dhaqangalayso Agosto 03, 2020

Bixiye

P62-20 CMS Decision on Acupuncture for Chronic Low Back Pain

Wax badan akhri

Taariikhda barnaamijka Dhaqangalayso Agosto 03, 2020

Bixiye

QP69-20 Commercial Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) Criteria: Risdiplam

Wax badan akhri

Taariikhda dhaqangalka Barnaamijka: Jul 22, 2020

Bixiye

QP65-20 Commercial Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) Criteria: Satralizumab

Wax badan akhri

Taariikhda dhaqangalka Barnaamijka: Jul 22, 2020

Bixiye

QP66-20 Updates to Injectable Drug Authorization Requests

Wax badan akhri

Taariikhda dhaqangalka Barnaamijka: Jul 22, 2020

Bixiye

QP64-20 Medical Drug Update for New to Market Viltolarsen

Wax badan akhri

Taariikhda dhaqangalka Barnaamijka: Jul 22, 2020

Bixiye

QP68-20 MHCP Pharmacy Benefit Update - Eylea®, Iluvien®, Lucentis®, Ozurdex® ,Retisert™ and Yutiq®

Wax badan akhri

Taariikhda dhaqangalka Barnaamijka: Jul 22, 2020

Bixiye

QP62-20 Medicaid Sleep Management – Home Sleep Studies

Wax badan akhri

Taariikhda dhaqangalka Barnaamijka: Jul 22, 2020

Bixiye

QP67-20 Commercial Pharmacy Benefit Exclusion for DurystaTM, Iluvien®, Retisert® and Yutiq®

Wax badan akhri

Taariikhda dhaqangalka Barnaamijka: Jul 22, 2020

Bixiye

QP63-20 MDH Guidance to Support Hospital Patients with Disabilities and Pediatric Patients

Wax badan akhri

Taariikhda dhaqangalka Barnaamijka: Jul 22, 2020